Back to Search
Start Over
Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria
- Source :
- Duffy, M F, Noviyanti, R, Tsuboi, T, Feng, Z-P, Trianty, L, Sebayang, B F, Takashima, E, Sumardy, F, Lampah, D A, Turner, L, Lavstsen, T, Fowkes, F J I, Siba, P, Rogerson, S J, Theander, T G, Marfurt, J, Price, R N, Anstey, N M, Brown, G V & Papenfuss, A T 2016, ' Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria ', Malaria Journal, vol. 15, 258 . https://doi.org/10.1186/s12936-016-1296-4, Malaria Journal
- Publication Year :
- 2016
-
Abstract
- Background Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants are encoded by var genes and mediate pathogenic cytoadhesion and antigenic variation in malaria. PfEMP1s can be broadly divided into three principal groups (A, B and C) and they contain conserved arrangements of functional domains called domain cassettes. Despite their tremendous diversity there is compelling evidence that a restricted subset of PfEMP1s is expressed in severe disease. In this study antibodies from patients with severe and uncomplicated malaria were compared for differences in reactivity with a range of PfEMP1s to determine whether antibodies to particular PfEMP1 domains were associated with severe or uncomplicated malaria. Methods Parts of expressed var genes in a severe malaria patient were identified by RNAseq and several of these partial PfEMP1 domains were expressed together with others from laboratory isolates. Antibodies from Papuan patients to these parts of multiple PfEMP1 proteins were measured. Results Patients with uncomplicated malaria were more likely to have antibodies that recognized PfEMP1 of Group C type and recognized a broader repertoire of group A and B PfEMP1s than patients with severe malaria. Conclusion These data suggest that exposure to a broad range of group A and B PfEMP1s is associated with protection from severe disease in Papua, Indonesia. Electronic supplementary material The online version of this article (doi:10.1186/s12936-016-1296-4) contains supplementary material, which is available to authorized users.
- Subjects :
- 0301 basic medicine
Adult
Male
Adolescent
030106 microbiology
Protozoan Proteins
Antibodies, Protozoan
macromolecular substances
Group A
03 medical and health sciences
Young Adult
Severe malaria
var genes
parasitic diseases
medicine
Antigenic variation
Humans
Malaria, Falciparum
Gene
reproductive and urinary physiology
biology
Research
Plasmodium falciparum
biology.organism_classification
medicine.disease
Acquired immune system
Virology
3. Good health
PfEMP1
030104 developmental biology
Infectious Diseases
Parasitology
Indonesia
Child, Preschool
Immunology
embryonic structures
biology.protein
Female
Antibody
Malaria
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Duffy, M F, Noviyanti, R, Tsuboi, T, Feng, Z-P, Trianty, L, Sebayang, B F, Takashima, E, Sumardy, F, Lampah, D A, Turner, L, Lavstsen, T, Fowkes, F J I, Siba, P, Rogerson, S J, Theander, T G, Marfurt, J, Price, R N, Anstey, N M, Brown, G V & Papenfuss, A T 2016, ' Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria ', Malaria Journal, vol. 15, 258 . https://doi.org/10.1186/s12936-016-1296-4, Malaria Journal
- Accession number :
- edsair.doi.dedup.....18a0aaa39c7501bd0386dbb1306f2a29
- Full Text :
- https://doi.org/10.1186/s12936-016-1296-4